Affected investors can register their claims for this company on the Sina Investor Rights Protection Platform.
On December 29, ST Renfu announced that the company and its controlling shareholder received the "Prior Notice of Administrative Penalty" from the Hubei Regulatory Bureau. The company and related entities are suspected of multiple information disclosure violations, involving issues such as non-operational fund occupation, undisclosed related-party transactions, and false entries in annual reports.
Renfu Pharma was fined 8.5 million yuan by regulators; its former controlling shareholder, Contemporary Group, was fined 9 million yuan; relevant responsible persons were also penalized accordingly.
Regarding the ensuing investor compensation matters, cases represented by the lawyer team of Liu Peng from Shanghai Huzi Law Firm have been submitted for acceptance in sequence and are still recruiting affected investors.
Investors who purchased shares between April 27, 2021, and October 22, 2024 (inclusive), and suffered losses by selling or still holding them after October 23, 2024, can still join the claim.
The illegal facts confirmed by the Hubei Securities Regulatory Bureau's investigation reveal a series of违规 operations by Renfu Pharma and its former controlling shareholder, "Contemporary Group," over several years.
From 2020 to 2022, ST Renfu and Contemporary Group were involved in multiple violations: Firstly, cumulative non-operational fund occupation of 12.785 billion yuan was not disclosed promptly, and this information was omitted from the 2020 annual report; secondly, a 1.645 billion yuan property asset transaction between a subsidiary and a related party in March 2022 was not disclosed timely and was excluded from that year's annual report; thirdly, multiple semi-annual financial reports from 2020 to 2022 contained false entries, cumulatively inflating net profit attributable to the parent company's shareholders by over 300 million yuan; fourthly, Contemporary Group concealed关联 relationships, leading to the company's failure to disclose关联 information as required for a 100 million yuan equity acquisition transaction.
The stringent penalties imposed by regulators serve both as a reckoning for past violations and provide a clear basis for affected investors to seek compensation.
Liu Peng, a lawyer from Shanghai Huzi Law Firm, pointed out: For shareholders who have already suffered losses as a result, the law provides a viable avenue to recover damages. Proactive rights protection is the correct path to safeguard one's legitimate interests.
(This article is contributed by Lawyer Liu Peng of Shanghai Huzi Law Firm and does not represent the views of Sina Finance. Lawyer Liu Peng, specializing in securities rights protection for 19 years, has successfully represented中小 investors of over 300 listed companies including Zhongqingbao, Guohua Wangan, and Jinjia Co., Ltd. since commencing practice in 2006. With over 14,000 cases in progress and a success rate of 99.2%, as a seasoned securities rights protection lawyer, Liu Peng accurately grasps case核心, possesses extensive litigation experience, and employs efficient claim strategies to maximize investor权益, leading the industry in维权 strength. Choosing the right lawyer is crucial for securities rights protection! Professionalism determines the odds of success, experience ensures outcomes; choose Lawyer Liu Peng first to make your claim more secure and efficient!)
Comments